Preliminary results of V3 loop peptide-primary neutralizing domain conjugate phase 1 vaccine trail. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Preliminary results of V3 loop peptide-primary neutralizing domain conjugate phase 1 vaccine trail.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S149-53. Unique Identifier : AIDSLINE MED/95169472
Rubinstein A; Goldstein H; Pettoello-Mantovani M; Cryz SJ; Department of Pediatrics, Microbiology, and Immunology, Albert; Einstein College of Medicine, Bronx, New York 10461.

Keywords: Amino Acid Sequence AIDS Vaccines/ADVERSE EFFECTS/IMMUNOLOGY/*PHARMACOLOGY Cross Reactions Human HIV Antibodies/BLOOD HIV Antigens/GENETICS HIV Envelope Protein gp120/GENETICS/*IMMUNOLOGY HIV-1/GENETICS/*IMMUNOLOGY IgG/BLOOD/CLASSIFICATION Immunization Schedule Molecular Sequence Data Neutralization Tests Peptide Fragments/GENETICS/*IMMUNOLOGY Safety Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. T-Lymphocytes, Cytotoxic/IMMUNOLOGY Tuberculin/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/IMMUNOLOGY Tuberculin Test Vaccines, Conjugate/ADVERSE EFFECTS/IMMUNOLOGY/PHARMACOLOGY CLINICAL TRIAL CLINICAL TRIAL, PHASE I JOURNAL ARTICLEKWDaminoacidsequenceaidsvaccines/adverseeffects/immunology/KWDpharmacologycrossreactionshumanhivantibodies/bloodhivantigens/geneticshivenvelopeproteingp120/genetics/KWDimmunologyhiv-1/genetics/KWDimmunologyigg/blood/classificationimmunizationschedulemolecularsequencedataneutralizationtestspeptidefragments/genetics/KWDimmunologysafetysupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDt-lymphocytes,cytotoxic/immunologytuberculin/administration&dosage/adverseeffects/immunologytuberculintestvaccines,conjugate/adverseeffects/immunology/pharmacologyclinicaltrialclinicaltrial,phaseijournalarticle
950630
M9561144

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .